These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 28953672)
1. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials. Zhao X; Xia S; Chen Y Medicine (Baltimore); 2017 Sep; 96(39):e8174. PubMed ID: 28953672 [TBL] [Abstract][Full Text] [Related]
2. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial. Park DH; Chung JK; Seo DR; Lee SJ Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791 [TBL] [Abstract][Full Text] [Related]
3. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials. Liu S; Yang G; Li Q; Tang S Indian J Ophthalmol; 2023 Apr; 71(4):1304-1315. PubMed ID: 37026262 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery. Baek J; Doh SH; Chung SK Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials. Nam K; Kim HJ; Yoo A Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362 [TBL] [Abstract][Full Text] [Related]
7. A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery. Kim S; Shin J; Lee JE Sci Rep; 2021 Apr; 11(1):9124. PubMed ID: 33907267 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Diquafosol Ophthalmic Solution on Clinical Parameters and Visual Function in Soft Contact Lens-Related Dry Eye. Ogami T; Asano H; Hiraoka T; Yamada Y; Oshika T Adv Ther; 2021 Nov; 38(11):5534-5547. PubMed ID: 34590267 [TBL] [Abstract][Full Text] [Related]
9. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study. Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373 [No Abstract] [Full Text] [Related]
10. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals. Utsunomiya T; Kawahara A; Hanada K; Yoshida A Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084 [TBL] [Abstract][Full Text] [Related]
11. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition. Shigeyasu C; Yamada M; Akune Y; Tsubota K Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials. Wu D; Chen WQ; Li R; Wang Y Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234 [TBL] [Abstract][Full Text] [Related]
13. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017 [TBL] [Abstract][Full Text] [Related]
14. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome. Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial. Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K; Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038 [TBL] [Abstract][Full Text] [Related]
16. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye. Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685 [TBL] [Abstract][Full Text] [Related]
17. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Topical Cyclosporine and Diquafosol Treatment in Dry Eye. Yang JM; Choi W; Kim N; Yoon KC Optom Vis Sci; 2015 Sep; 92(9):e296-302. PubMed ID: 26107023 [TBL] [Abstract][Full Text] [Related]
19. Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study. Miyake K; Yokoi N Clin Ophthalmol; 2017; 11():529-540. PubMed ID: 28360509 [TBL] [Abstract][Full Text] [Related]
20. Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye. Kaido M; Kawashima M; Shigeno Y; Yamada Y; Tsubota K Adv Ther; 2018 May; 35(5):697-706. PubMed ID: 29671255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]